$32 million for New Antifungal Drug Development & New Antifungal Treatment Strategies
K2 therapeutics was only founded 2 years ago in San Diego, California with $6 million funding and has successfully developed a candidate for a new antifungal drug referred to as Biafungin. Much is unknown outside the company about this new compound but early testing has provided sufficient encouragement for new investors to fund a further $32 million.
Enhanced stability of Biafungin
A
Enhanced stability of Biafungin
A
0 Response to "$32 million for New Antifungal Drug Development & New Antifungal Treatment Strategies"
Post a Comment